Nasdaq nstg.

According to the issued ratings of 6 analysts in the last year, the consensus rating for NanoString Technologies stock is Hold based on the current 4 hold ratings and 2 buy ratings for NSTG. The average twelve-month price prediction for NanoString Technologies is $7.63 with a high price target of $10.00 and a low price target of $2.50.

Nasdaq nstg. Things To Know About Nasdaq nstg.

NanoString Technologies ( NASDAQ: NSTG) said it is collaborating with digital pathology software company Visiopharm to discover novel biomarkers and drug targets using spatial imaging and machine ...NanoString Technologies, Inc. (NASDAQ:NSTG) shares fell 46% to $0.69. TD Cowen downgraded NanoString Technologies from Outperform to Market Perform and lowered the price target from $6 to $1.4.Barron's 400. Market Data. NSTG. U.S.: Nasdaq. Average price target from. 0.4710 - 13.2000. 115.14K (6.09% of Avg) Pacific Biosciences of California Inc. Agilent …SEATTLE, May 12, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., (Nasdaq:NSTG) a provider of life science tools for translational research and...NanoString Technologies (NSTG) came out with a quarterly loss of $0.95 per share versus the Zacks Consensus Estimate of a loss of $0.61. This compares to loss of $0.64 per share a year ago.

The NSTG stock price is -964.52% off its 52-week high price of $13.20 and 17.74% above the 52-week low of $1.02. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.09 million shares traded. The 3-month trading volume is 1.44 million shares. Nanostring Technologies Inc (NASDAQ:NSTG) trade information

Nov 21, 2023 · Fintel reports that on November 21, 2023, Baird downgraded their outlook for Nanostring Technologies (NASDAQ:NSTG) from Outperform to Neutral . Analyst Price Forecast Suggests 1,436.84% Upside As ...

The company will release Q3 FY23 results on November 6, 2023. Price Action: NSTG shares are up by 10.0% at $1.32 premarket on the last check Tuesday. NanoString Technologies Inc (NASDAQ:NSTG ...Nov 28, 2023 · NanoString Technologies has a one year low of $0.47 and a one year high of $13.20. The firm has a market capitalization of $26.74 million, a PE ratio of -0.16 and a beta of 1.67. The company has a debt-to-equity ratio of 16.67, a quick ratio of 2.02 and a current ratio of 2.73. NanoString Technologies ( NASDAQ:NSTG – Get Free Report) last ... SEATTLE, March 18, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...SEATTLE and CAMBRIDGE, UK, April 01, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic ...NanoString Technologies, Inc. Common Stock (NSTG) Earnings Report Date | Nasdaq. Created with Sketch. Zacks earnings numbers are reported on a BNRI (Before Non Recurring Items) basis and include ...

SEATTLE, Oct. 04, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...

Nanostring Technologies Inc (NASDAQ:NSTG) trade information. Instantly NSTG is in green as seen in intraday trades today. With action -58.61%, the performance over the past five days has been red. The jump to weekly highs of 1.4100 on Tuesday, 11/21/23 added 9.33% to the stock’s daily price.

JP Morgan has downgraded NanoString ( NASDAQ: NSTG) to neutral due to limited near-term visibility amid ongoing patent litigation. The investment bank noted that NanoString is embroiled in ongoing ...NanoString Technologies, Inc. Common Stock (NSTG) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. 10x Genomics (NASDAQ:TXG) on Wednesday said it had been awarded an injunction by a German court in its patent litigation against NanoString Technologies (NASDAQ:NSTG). NSTG stock fell 6.6% to $7. ...Within the last quarter, NanoString Technologies (NASDAQ:NSTG) has observed the following analyst ratings: According to 5 analyst offering 12-month price targets in the last 3 months, NanoString ...Fiscal Q3 2023 ended 9/30/23. Reported on 11/6/23. Get the latest NanoString Technologies Inc (NSTG) real-time quote, historical performance, charts, and other financial information to help you... Below is a chart showing NSTG's trailing twelve month trading history, with the $10 strike highlighted in orange: Cisco Systems Inc (Symbol: CSCO) options are showing a volume of 97,085 contracts ...SEATTLE, January 19, 2023--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced a public release of new ...

EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission. Find the latest Financials data for NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com. Nov 20, 2023 · Nanostring Technologies Inc (NASDAQ:NSTG) trade information. Instantly NSTG was in red as seen at the end of in last trading. With action 18.52%, the performance over the past five days has been green. The drop to weekly highs of 1.4100 on Friday, 11/17/23 subtracted -3.76% to the stock’s daily price. Nov 20, 2023 · Founded in 1999, MT Newswires (formerly known as Midnight Trader) is a leading provider of original source, multi-asset class, real-time, global financial news and information to most of the ... Fintel reports that on September 19, 2023, Canaccord Genuity reiterated coverage of Nanostring Technologies (NASDAQ:NSTG) with a Buy recommendation.. Analyst Price Forecast Suggests 786.10% Upside ...SEATTLE, May 12, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., (Nasdaq:NSTG) a provider of life science tools for translational research and...NanoString Technologies Inc (NASDAQ:NSTG) 0.4957 Delayed Data As of Nov 30 -0.0069 / -1.37% Today’s Change 0.47 Today ||| 52-Week Range 13.20 -93.78% Year-to-Date Quote Profile News Charts...PLEASANTON, Calif., May 17, 2023 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG ), a leader in single cell and spatial biology, today announced that it has won an injunction in its patent ...

Find the latest Insider Activity data for NanoString Technologies, Inc. Common Stock (NSTG) at Nasdaq.com.

We will take a look at NanoString Technologies Inc (NASDAQ:NSTG), Chimera Investment Corporation (NYSE:CIM), Renewable Energy Group Inc (NASDAQ:REGI), Sogou Inc. (NYSE:SOGO), Live Oak Bancshares ...NanoString Technologies ( NASDAQ: NSTG) said it is collaborating with digital pathology software company Visiopharm to discover novel biomarkers and drug targets using spatial imaging and machine ...Sep 19, 2023 · NanoString Technologies (NSTG) fell 10% on a report that a German court announced a preliminary injunction against it over a patent dispute with 10X Genomics (TXG). 10x Genomics rose 0.5% Nov 28, 2023 · NanoString Technologies has a one year low of $0.47 and a one year high of $13.20. The firm has a market capitalization of $26.74 million, a PE ratio of -0.16 and a beta of 1.67. The company has a debt-to-equity ratio of 16.67, a quick ratio of 2.02 and a current ratio of 2.73. NanoString Technologies ( NASDAQ:NSTG – Get Free Report) last ... The latest price target for NanoString Technologies (NASDAQ: NSTG) was reported by Canaccord Genuity on Monday, November 27, 2023. The analyst firm set a price ...Nike, Inc. has no single specific owner. According to Nasdaq, the company is a publicly traded one, with its shares listed on the New York Stock Exchange under the symbol NKE. As of May, 2014, 83.29 percent of Nike’s shares were owned by in...SEATTLE and TOKYO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, and ...SEATTLE, Sept. 10, 2015 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...Average. $4.86. Current Price. $0.55. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ...

"NanoString Technologies, Inc. (NASDAQ:NSTG): NSTG is a leader in spatial biology, offering a platform of products that help researchers map biology down to a single-cell. Since our purchase of NSTG at the inception of the strategy nearly five years ago, the company has significantly widened its technology platform and products, …

SEATTLE, Feb. 29, 2016 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...

A. The latest price target for NanoString Technologies ( NASDAQ: NSTG) was reported by Baird on Tuesday, November 21, 2023. The analyst firm set a price target for 0.75 expecting NSTG to rise to ...Webull offers NSTG Ent Holdg (NSTG) historical stock prices, in-depth market analysis, NASDAQ: NSTG real-time stock quote data, in-depth charts, free NSTG ...NSTG Stock Price | NanoString Technologies Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch. NSTG | Complete NanoString Technologies Inc. stock news by …SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and ...NSTG NASDAQ. NSTG NASDAQ. NSTG NASDAQ. Market closed Market closed. No trades. See on Supercharts. Overview News Ideas Financials Technicals . Forecast . Price target. 4.86 0.00 0.00%. The 6 analysts offering 1 year price forecasts for NSTG have a max estimate of — and a min estimate of —. Analyst rating.SEATTLE, March 27, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ...According to the issued ratings of 6 analysts in the last year, the consensus rating for NanoString Technologies stock is Hold based on the current 4 hold ratings and 2 buy ratings for NSTG. The average twelve-month price prediction for NanoString Technologies is $7.63 with a high price target of $10.00 and a low price target of $2.50.Maybe you’ve never invested before. Maybe you have no clue what the difference is between NASDAQ and the New York Stock Exchange. Regardless, the name Charles Schwab probably rings a bell.

NanoString Technologies (NASDAQ: NSTG) is a publicly held provider of life science tools for translational research and molecular diagnostics. The company's technology enables a wide variety of basic research, translational medicine and in vitro diagnostics applications. NanoString's products are based on a novel digital molecularFind the latest NanoString Technologies, Inc. (NSTG) stock quote, history, news and other vital information to help you with your stock trading and investing.According to regulatory filings on Wednesday, Gray had bought ~67.6K NSTG shares at $7.38 apiece on Dec. 12, raising his stake at the company by ~33% to ~270.0K after a transaction worth $499.4K ...Instagram:https://instagram. stock wafdnew hydrogen stockscanada forex brokerquantom energy SEATTLE and CAMBRIDGE, UK, April 01, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic ... phone payment plan cricketfortigate stock SEATTLE, March 26, 2019 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today ... axcellis Owkin, Nanostring (NASDAQ:NSTG), and world-leading cancer research institutions University of Pittsburgh, Gustave Roussy, Lausanne University Hospital, Uniklinikum Erlangen/Friedrich-Alexander-Universität Erlangen-Nürnberg, and Charité - Universitätsmedizin Berlin are launching MOSAIC (Multi Omic Spatial Atlas In Cancer) at …NanoString ( NASDAQ: NSTG) lost half of its market value on Monday after a legal setback in Delaware over a patent dispute prompted the life sciences company to withdraw its guidance. On Friday ...